Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: A novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator

Craig M. Pratt, Paul Dorian, Hussein R. Al-Khalidi, Jose M. Brum, Martin Borggrefe, Daljit S. Tatla, Johannes Brachmann, Robert J. Myerburg, David S. Cannom, Michael J. Holroyde, Michael Van Der Laan, Stefan H. Hohnloser

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: A novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases